BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 22261394)

  • 1. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
    Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH
    Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
    Yeung JH; Or PM
    Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interaction between Astragali Radix and Rehmanniae Radix in a Chinese herbal formula to promote diabetic wound healing.
    Lau KM; Lai KK; Liu CL; Tam JC; To MH; Kwok HF; Lau CP; Ko CH; Leung PC; Fung KP; Poon SK; Lau CB
    J Ethnopharmacol; 2012 May; 141(1):250-6. PubMed ID: 22366433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers.
    Yi S; Cho JY; Lim KS; Kim KP; Kim J; Kim BH; Hong JH; Jang IJ; Shin SG; Yu KS
    Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):249-56. PubMed ID: 19422358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro.
    Wang X; Cheung CM; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2010 Sep; 17(11):868-75. PubMed ID: 20638257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
    Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
    Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE; Ahern D; Scatina J; Kao J
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.
    Liu KH; Kim MJ; Jeon BH; Shon JH; Cha IJ; Cho KH; Lee SS; Shin JG
    J Clin Pharm Ther; 2006 Feb; 31(1):83-91. PubMed ID: 16476124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme kinetic and molecular docking studies on the metabolic interactions of 1-hydroxy-2,3,5-trimethoxy-xanthone, isolated from Halenia elliptica D. Don, with model probe substrates of human cytochrome P450 enzymes.
    Feng R; Zhou X; Or PM; Ma JY; Tan XS; Fu J; Ma C; Shi JG; Che CT; Wang Y; Yeung JH
    Phytomedicine; 2012 Sep; 19(12):1125-33. PubMed ID: 22819301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profiling of human skin fibroblast cell line Hs27 induced by herbal formula Astragali Radix and Rehmanniae Radix.
    Zhang Q; Wei F; Fong CC; Yu WK; Chen Y; Koon CM; Lau KM; Leung PC; Lau CB; Fung KP; Yang M
    J Ethnopharmacol; 2011 Dec; 138(3):668-75. PubMed ID: 22075453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes.
    Nakajima M; Kobayashi K; Oshima K; Shimada N; Tokudome S; Chiba K; Yokoi T
    Xenobiotica; 1999 Sep; 29(9):885-98. PubMed ID: 10548449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs.
    Nakajima M; Nakamura S; Tokudome S; Shimada N; Yamazaki H; Yokoi T
    Drug Metab Dispos; 1999 Dec; 27(12):1381-91. PubMed ID: 10570018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium tanshinone IIA sulfonate and its interactions with human CYP450s.
    Chen D; Lin XX; Huang WH; Zhang W; Tan ZR; Peng JB; Wang YC; Guo Y; Hu DL; Chen Y
    Xenobiotica; 2016 Dec; 46(12):1085-1092. PubMed ID: 26932161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro.
    Störmer E; Brockmöller J; Roots I; Schmider J
    Psychopharmacology (Berl); 2000 Sep; 151(4):312-20. PubMed ID: 11026737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing effect of a two-herb recipe (NF3) on foot ulcers in Chinese patients with diabetes: a randomized double-blind placebo-controlled study.
    Ko CH; Yi S; Ozaki R; Cochrane H; Chung H; Lau W; Koon CM; Hoi SW; Lo W; Cheng KF; Lau CB; Chan WY; Leung PC; Chan JC
    J Diabetes; 2014 Jul; 6(4):323-34. PubMed ID: 24330156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes.
    Albassam AA; Ahad A; Alsultan A; Al-Jenoobi FI
    Saudi Pharm J; 2018 Jul; 26(5):673-677. PubMed ID: 29989011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.